Daxor Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a diversified, closed-end management investment company. Its focus and operations are as a medical device manufacturing, company. The company specializes in blood volume measurement technology focused on blood volume testing innovation. The company markets the Blood Volume Analyzer (BVA)-100, the diagnostic blood test cleared by the FDA to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000 tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. Its facility provides on-demand, next day blood volume analysis results. The company has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the United States Department of Defense.
Mr. Michael Feldschuh es el Chairman of the Board de Daxor Corp, se unió a la empresa desde 2013.
¿Qué tal es el rendimiento del precio de la acción DXR?
El precio actual de DXR es de $10.13, ha disminuido un 3.61% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Daxor Corp?
Daxor Corp pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Daxor Corp?
La capitalización bursátil actual de Daxor Corp es $59.0M
¿Es Daxor Corp una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 4 analistas han realizado calificaciones de análisis para Daxor Corp, incluyendo 1 fuerte compra, 4 compra, 1 mantener, 0 venta, y 1 fuerte venta